Tykerb is the brand name for a new anti-cancer medication called lapatinib. Tykerb works by inhibiting kinase proteins in cells which interferes with the growth of cancer cells. Tykerb is used in combination with another anti-cancer drug called capecitabine (Xeloda), for the treatment of advanced breast cancer that is positive for the HER2 protein.
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.
